West Synchrony™ S1 Prefillable Syringe System Commercially Available at Pharmapack
Rhea-AI Summary
West Pharmaceutical Services (NYSE: WST) announced the global commercial availability of the West Synchrony™ S1 prefillable syringe (PFS) system at Pharmapack 2026 in Paris on January 20, 2026. The system offers 1 ml long and 2.25 ml staked needle options for biologics, plus 1 ml standard staked needle and Luer lock options for vaccines, with rigid or soft needle shields and integrated tip caps. The platform includes West NovaPure® and FluroTec™ barrier film plungers. West will present learning labs and a product gallery at Pharmapack on January 21–22, 2026 to highlight integrated solutions and combination-product support.
Positive
- None.
Negative
- None.
Key Figures
Market Reality Check
Peers on Argus
While WST fell 7.02%, key peers moved modestly: HOLX -0.03%, BAX -0.45%, SOLV -0.75%, COO +0.07%, RMD -0.98%. The magnitude of WST’s decline diverges from generally small peer moves, pointing to a stock-specific reaction rather than a sector-wide move.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Jan 12 | Asset sale / facility | Positive | -0.9% | AbbVie agreed to acquire Tempe device facility and related IP from West. |
| Jan 12 | Product rights sale | Positive | -0.9% | West to sell SmartDose 3.5mL manufacturing and supply rights to AbbVie for cash. |
| Dec 12 | Investor conference | Neutral | -1.8% | Announcement of presentation at the J.P. Morgan Healthcare Conference with webcast. |
| Dec 10 | Dividend declaration | Positive | +0.3% | Board declared a regular quarterly dividend of $0.22 per share with set dates. |
| Oct 27 | Product launch | Positive | -3.5% | Launch of West Synchrony Prefillable Syringe System with availability in Jan 2026. |
Recent history shows multiple instances where seemingly positive strategic or product news for WST coincided with negative short-term price reactions, suggesting a tendency toward sell-the-news behavior.
Over the past few months, West has reported stronger Q3 2025 results, including net sales of $804.6 million and diluted EPS of $1.92, alongside active capital returns. Strategic portfolio shaping continued with agreements to sell the SmartDose 3.5mL system and an Arizona manufacturing facility to AbbVie, both expected to close in mid-2026. The Synchrony prefillable syringe system was first launched at CPHI with commercial availability targeted for January 2026, and today’s Pharmapack announcement confirms that global commercial availability milestone.
Market Pulse Summary
This announcement confirms global commercial availability of the West Synchrony S1 prefillable syringe system, expanding options for biologics and vaccines with 1 ml and 2.25 ml configurations and multiple needle and Luer lock setups. It builds on the prior CPHI launch, where availability in January 2026 was first flagged. In parallel, West recently reported stronger Q3 results with net sales of $804.6 million and diluted EPS of $1.92, providing a financial backdrop as this new system enters the market.
Key Terms
combination products technical
AI-generated analysis. Not financial advice.
Showcasing Leadership in Drug Delivery Solutions and Approaches to Combination Products
West Synchrony S1 PFS system provides a broad product portfolio including 1 ml long and 2.25 ml staked needle options for biologics and 1 ml standard staked needle and Luer lock options for vaccines. Staked needle system options come with either a rigid or soft needle shield and Luer lock system options will have an integrated tip cap. The system also includes high performance West NovaPure® and FluroTec™ barrier film plungers.
"As a market leader, West closely monitors shifts in the global drug pipeline by emerging companies, particularly the growing demand for combination products alongside the movement of care from hospital to home, both of which introduce new complexity into regulatory and development processes," Stacey Vaughan, Vice President, Marketing and Portfolio Management at West. "This surge of innovation across the industry further highlights why now is the right time to introduce West Synchrony S1 prefillable syringe system."
In addition, West will highlight its industry expertise through learning labs and a product gallery:
- Stop Piecing It Together—Get an Integrated Verified Prefillable Syringe System from One Source- Wednesday, January 21, 11:30 a.m.- 12:00 p.m. CET
- Presented by Bettine Boltres Ph.D., Director of Scientific Affairs
- Product Gallery- West Synchrony S1 PFS System- Wednesday, January 21, 3:25-3:30 p.m. CET
- Presented by Andy Polywacz, President of Integrated Systems
- Flexible Assembly and Packaging Approach for Steering Combination Products Through Clinical Trials- Thursday, January 22, 10:10- 10:40 a.m. CET
- Presented by Richard Kieran, Director of Business Development
For more information about West Synchrony S1 PFS system, click here.
For more information about Pharmapack, click here.
Forward-Looking Statements
Certain forward-looking statements are included in this press release. They use words such as "standard," "streamline," "accelerate," "secures," "reliable," "meets," and other similar terminology. These statements reflect management's current expectations regarding future events and operating performance and speak only as of the date of this release. There is no certainty that actual results will be achieved in-line with current expectations. Specifically, there is no certainty that West's introduction of the Synchrony PFS system will achieve any particular result. These forward-looking statements involve a number of risks and uncertainties. Various factors could cause the actual results to differ materially from those expressed in, or underlying, these forward-looking statements, such as customers' changing inventory requirements and manufacturing plans; customer decisions to move forward with new products and product categories; average profitability, or mix, of the products offered for sale; dependence on third party suppliers and partners; interruptions or weaknesses in the supply chain; increased raw material costs; fluctuations in currency exchange; and the ability to meet development milestones with key customers. These important factors are not all inclusive. For a description of certain additional factors that could cause West's future results to differ from those expressed in any such forward-looking statements, see Item 1A, entitled "Risk Factors," in West's Annual Report on Form 10-K for the year ended December 31, 2024. Except as required by law or regulation, West undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events, or otherwise.
About West
West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of lifesaving and life-enhancing medicines for patients. With over 10,000 team members across 50 sites including 25 manufacturing facilities worldwide, West helps support our customers by delivering over 41 billion components and devices each year.
Headquartered in
All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted.
View original content to download multimedia:https://www.prnewswire.com/news-releases/west-synchrony-s1-prefillable-syringe-system-commercially-available-at-pharmapack-302664737.html
SOURCE West Pharmaceutical Services, Inc.
FAQ
What is the West Synchrony S1 prefillable syringe system that WST announced on January 20, 2026?
Where and when did West (WST) announce commercial availability of the Synchrony S1 system?
Which syringe configurations does the West Synchrony S1 system include for vaccines and biologics?
What protective features are offered with West Synchrony S1 staked needle and Luer lock options?
How is West showcasing the Synchrony S1 system at Pharmapack and who are the presenters?
